aTyr Pharma Inc LIFE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.69quote price arrow down-0.01 (-0.59%)
Volume
270,197
52 week range
1.08 - 2.70
Loading...
  • Open1.68
  • Day High1.72
  • Day Low1.63
  • Prev Close1.70
  • 52 Week High2.70
  • 52 Week High Date05/15/23
  • 52 Week Low1.08
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap116.628M
  • Shares Out69.01M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change19.86

KEY STATS

  • Open1.68
  • Day High1.72
  • Day Low1.63
  • Prev Close1.70
  • 52 Week High2.70
  • 52 Week High Date05/15/23
  • 52 Week Low1.08
  • 52 Week Low Date11/13/23
  • Market Cap116.628M
  • Shares Out69.01M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change19.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-1.87
  • Fwd P/E (NTM)-1.84
  • EBITDA (TTM)-58.078M
  • ROE (TTM)-55.50%
  • Revenue (TTM)588,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-9,172.11%
  • Debt To Equity (MRQ)2.14%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On aTyr Pharma Inc

 

Profile

MORE
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause inflammation and fibrosis, or scarring, of the lungs. Efzofitimod is a tRNA synthetase...
John Clarke
Independent Chairman of the Board
Sanjay Shukla M.D.
President, Chief Executive Officer, Director
Jill Broadfoot
Chief Financial Officer
Nancy Denyes J.D.
General Counsel, Corporate Secretary
Address
10240 Sorrento Valley Road, Suite 300
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
VIGL
Vigil Neuroscience Inc
3.78+0.59+18.50%
GLYC
GlycoMimetics Inc
0.2984-0.007-2.2921%
GNLX
Genelux Corp
3.79+0.14+3.84%
ACET
Adicet Bio Inc
1.65-0.08-4.62%
OTLK
Outlook Therapeutics Inc
8.00-0.21-2.56%